Redox Signaling as a Therapeutic Target to Inhibit Myofibroblast Activation in Degenerative Fibrotic Disease

Degenerative fibrotic diseases encompass numerous systemic and organ-specific disorders. Despite their associated significant morbidity and mortality, there is currently no effective antifibrotic treatment. Fibrosis is characterized by the development and persistence of myofibroblasts, whose unregul...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampson, Natalie, Berger, Peter, Zenzmaier, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950649/
https://www.ncbi.nlm.nih.gov/pubmed/24701562
http://dx.doi.org/10.1155/2014/131737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950649/
https://www.ncbi.nlm.nih.gov/pubmed/24701562
http://dx.doi.org/10.1155/2014/131737

Ejemplares similares